Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-10-047212
Filing Date
2010-08-30
Accepted
2010-08-30 07:53:35
Documents
2
Period of Report
2010-08-30

Document Format Files

Seq Description Document Type Size
1 v195576_6k.htm 6-K 1394757
2 GRAPHIC logo.jpg GRAPHIC 9816
  Complete submission text file 0001144204-10-047212.txt   1409807
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 101045371
SIC: 2834 Pharmaceutical Preparations